
11-50 employees
Apogee Therapeutics is a clinical-stage biotechnology company focused on developing novel therapies to treat fibrotic diseases. Their mission is to transform the treatment landscape for patients suffering from fibrosis by targeting the underlying mechanisms of disease progression. The company leverages advanced scientific research to develop innovative drug candidates aimed at improving patient outcomes in areas with significant unmet medical needs. Apogee Therapeutics is committed to advancing its pipeline through rigorous clinical development and strategic collaborations.
📋
🏖️